TAKE Solutions Limited (TAKE.BO)
INR 16.89
(-0.18%)
INR 16.89
(-0.18%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -213.49 Million INR | 40.23% |
| 2022 | -357.16 Million INR | 44.89% |
| 2021 | -648.11 Million INR | 64.43% |
| 2020 | -1.82 Billion INR | -7103.34% |
| 2019 | 26.02 Million INR | -98.87% |
| 2018 | 2.31 Billion INR | 13.48% |
| 2017 | 2.03 Billion INR | 15.06% |
| 2016 | 1.77 Billion INR | 26.97% |
| 2015 | 1.39 Billion INR | 7.81% |
| 2014 | 1.29 Billion INR | 17.99% |
| 2013 | 1.09 Billion INR | -24.82% |
| 2012 | 1.45 Billion INR | 10.16% |
| 2011 | 1.32 Billion INR | 23.32% |
| 2010 | 1.07 Billion INR | 25.79% |
| 2009 | 853.07 Million INR | -6.43% |
| 2008 | 911.66 Million INR | 6.96% |
| 2007 | 852.35 Million INR | 69.24% |
| 2006 | 503.65 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -34.68 Million INR | -151.76% |
| 2023 FY | -213.49 Million INR | 40.23% |
| 2023 Q4 | -167.89 Million INR | -2225.35% |
| 2023 Q3 | -7.22 Million INR | -95.14% |
| 2023 Q2 | -3.7 Million INR | 89.33% |
| 2022 Q1 | -88.02 Million INR | 75.58% |
| 2022 FY | -357.16 Million INR | 44.89% |
| 2022 Q4 | 66.99 Million INR | 188.09% |
| 2022 Q3 | -76.06 Million INR | 76.03% |
| 2022 Q2 | -317.25 Million INR | -260.41% |
| 2021 Q3 | -403.17 Million INR | -2061.44% |
| 2021 Q2 | -18.65 Million INR | -132.78% |
| 2021 FY | -648.11 Million INR | 64.43% |
| 2021 Q1 | 56.9 Million INR | -59.88% |
| 2021 Q4 | -360.4 Million INR | 10.61% |
| 2020 FY | -1.82 Billion INR | -7103.34% |
| 2020 Q3 | -133.83 Million INR | 87.27% |
| 2020 Q2 | -1.05 Billion INR | -44.18% |
| 2020 Q4 | 141.84 Million INR | 205.98% |
| 2020 Q1 | -729.39 Million INR | 61.36% |
| 2019 Q4 | -1.88 Billion INR | -367.02% |
| 2019 Q1 | 653.62 Million INR | 83.43% |
| 2019 Q2 | 719.97 Million INR | 10.15% |
| 2019 Q3 | 706.94 Million INR | -1.81% |
| 2019 FY | 26.02 Million INR | -98.87% |
| 2018 Q1 | 686.59 Million INR | 12.18% |
| 2018 Q4 | 356.32 Million INR | -27.87% |
| 2018 FY | 2.31 Billion INR | 13.48% |
| 2018 Q3 | 493.98 Million INR | -37.74% |
| 2018 Q2 | 793.4 Million INR | 15.56% |
| 2017 Q1 | 460.92 Million INR | -4.34% |
| 2017 Q2 | 477.85 Million INR | 3.67% |
| 2017 FY | 2.03 Billion INR | 15.06% |
| 2017 Q3 | 536.56 Million INR | 12.29% |
| 2017 Q4 | 612.02 Million INR | 14.06% |
| 2016 FY | 1.77 Billion INR | 26.97% |
| 2016 Q3 | 482.9 Million INR | 6.22% |
| 2016 Q4 | 481.83 Million INR | -0.22% |
| 2016 Q2 | 454.64 Million INR | -0.53% |
| 2016 Q1 | 457.04 Million INR | -3.51% |
| 2015 Q4 | 473.69 Million INR | 46.7% |
| 2015 FY | 1.39 Billion INR | 7.81% |
| 2015 Q3 | 322.89 Million INR | -1.64% |
| 2015 Q1 | 472.6 Million INR | 69.93% |
| 2015 Q2 | 328.27 Million INR | -30.54% |
| 2014 Q2 | 200.98 Million INR | 9.6% |
| 2014 FY | 1.29 Billion INR | 17.99% |
| 2014 Q4 | 278.11 Million INR | 16.95% |
| 2014 Q3 | 237.8 Million INR | 18.32% |
| 2014 Q1 | 183.37 Million INR | 29.92% |
| 2013 Q2 | 212.58 Million INR | 11.68% |
| 2013 Q4 | 141.14 Million INR | -34.99% |
| 2013 Q1 | 190.35 Million INR | 15.66% |
| 2013 FY | 1.09 Billion INR | -24.82% |
| 2013 Q3 | 217.11 Million INR | 2.13% |
| 2012 FY | 1.45 Billion INR | 10.16% |
| 2012 Q4 | 164.58 Million INR | -38.9% |
| 2012 Q3 | 269.37 Million INR | -15.92% |
| 2012 Q2 | 320.38 Million INR | -19.09% |
| 2012 Q1 | 395.98 Million INR | 35.23% |
| 2011 Q3 | 349.65 Million INR | 8.06% |
| 2011 Q2 | 323.57 Million INR | 0.0% |
| 2011 FY | 1.32 Billion INR | 23.32% |
| 2011 Q4 | 292.81 Million INR | -16.26% |
| 2010 FY | 1.07 Billion INR | 25.79% |
| 2009 FY | 853.07 Million INR | -6.43% |
| 2008 FY | 911.66 Million INR | 6.96% |
| 2007 FY | 852.35 Million INR | 69.24% |
| 2006 FY | 503.65 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 9.28 Million INR | 2399.795% |
| Biocon Limited | 50.83 Billion INR | 100.42% |
| Blue Jet Healthcare Limited | 3.37 Billion INR | 106.331% |
| Concord Biotech Limited | 6.26 Billion INR | 103.409% |
| Dishman Carbogen Amcis Limited | -13.9 Million INR | -1435.899% |
| FERMENTA BIOTECH LIMITED | 1.06 Billion INR | 119.991% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.27 Million INR | 16834.47% |
| Lyka Labs Limited | 29.13 Million INR | 832.887% |
| Panacea Biotec Limited | -309.7 Million INR | 31.066% |
| SAMSRITA LABS LIMITED | -1.49 Million INR | -14157.57% |
| Servoteach Industries Limited | -785.00 INR | -27196078.344% |
| SMS Lifesciences India Limited | 359.47 Million INR | 159.39% |
| Supriya Lifescience Limited | 1.57 Billion INR | 113.584% |
| Syngene International Limited | 14.02 Billion INR | 101.522% |
| Titan Biotech Limited | 315.89 Million INR | 167.582% |
| Transgene Biotek Limited | -7.08 Million INR | -2911.567% |
| Vanta Bioscience Limited | -31.83 Million INR | -570.551% |